# MARA Holdings, Inc.: financial statements, quarterly

MARA · Nasdaq · CIK 1507605 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mara.md) · [Financials](/companies/mara/financials.md) · [Filings](/companies/mara/filings.md) · [Insiders](/companies/mara/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mara/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5.1](/filings/0001628280-24-047148.md) | [24.5 d](/filings/0001507605-26-000007.md) | [43.2](/filings/0001507605-25-000009.md) | [24.9](/filings/0001507605-25-000018.md) | [16.8](/filings/0001507605-25-000028.md) | [12.8 d](/filings/0001507605-26-000007.md) | [14.7](/filings/0001507605-26-000016.md) | [15.2](/filings/0001507605-26-000022.md) | [16.8](/filings/0001507605-25-000028.md) | [12.0 d](/filings/0001507605-26-000007.md) | [17.4](/filings/0001507605-26-000016.md) | [13.8](/filings/0001507605-26-000022.md) |
| Cost of revenue | $m | [113](/filings/0001628280-24-047148.md) | [146 d](/filings/0001507605-25-000003.md) | [168](/filings/0001628280-24-022243.md) | [182](/filings/0001628280-24-034196.md) | [199](/filings/0001628280-24-047148.md) | [267 d](/filings/0001507605-25-000003.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [(15.3)](/filings/0001628280-24-025261.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [0.7](/filings/0001628280-24-047148.md) | [1.2 d](/filings/0001507605-26-000007.md) | [2.5](/filings/0001507605-25-000009.md) | [3.8](/filings/0001507605-25-000018.md) | [2.8](/filings/0001507605-25-000028.md) | [4.1 d](/filings/0001507605-26-000007.md) | [9.3](/filings/0001507605-26-000016.md) | [8.5](/filings/0001507605-26-000022.md) | [8.7](/filings/0001507605-25-000028.md) | [3.6 d](/filings/0001507605-26-000007.md) | [8.2](/filings/0001507605-26-000016.md) | [7.2](/filings/0001507605-26-000022.md) |
| Operating income | $m | [(80.2)](/filings/0001628280-24-047148.md) | [185 d](/filings/0001507605-26-000007.md) | [370](/filings/0001507605-25-000009.md) | [(232)](/filings/0001507605-25-000018.md) | [(172)](/filings/0001507605-25-000028.md) | [341 d](/filings/0001507605-26-000007.md) | [(541)](/filings/0001507605-26-000016.md) | [680](/filings/0001507605-26-000022.md) | [47.6](/filings/0001507605-25-000028.md) | [(1,411) d](/filings/0001507605-26-000007.md) | [(1,061)](/filings/0001507605-26-000016.md) | [(521)](/filings/0001507605-26-000022.md) |
| Interest expense | $m | [2.5](/filings/0001493152-23-039927.md) | [1.2 d](/filings/0001628280-24-025261.md) | [1.3](/filings/0001628280-24-022243.md) | [1.4](/filings/0001507605-25-000018.md) | [2.3](/filings/0001507605-25-000028.md) | [8.0 d](/filings/0001507605-26-000007.md) | [9.9](/filings/0001507605-26-000016.md) | [12.8](/filings/0001507605-26-000022.md) | [12.8](/filings/0001507605-25-000028.md) | [12.8 d](/filings/0001507605-26-000007.md) | [10.7](/filings/0001507605-26-000016.md) | [6.3](/filings/0001507605-26-000022.md) |
| Income tax | $m | [0.1](/filings/0001628280-24-047148.md) | [16.1 d](/filings/0001507605-26-000007.md) | [38.1](/filings/0001507605-25-000009.md) | [(31.7)](/filings/0001507605-25-000018.md) | [(49.2)](/filings/0001507605-25-000028.md) | [118 d](/filings/0001507605-26-000007.md) | [(119)](/filings/0001507605-26-000016.md) | [209](/filings/0001507605-26-000022.md) | [37.7](/filings/0001507605-25-000028.md) | [(183) d](/filings/0001507605-26-000007.md) | [(30.9)](/filings/0001507605-26-000016.md) | [0.6](/filings/0001507605-26-000022.md) |
| Net income | $m | [(0.4)](/filings/0001628280-24-047148.md) | [152 d](/filings/0001507605-26-000007.md) | [337](/filings/0001628280-24-022243.md) | [(200)](/filings/0001628280-24-034196.md) | [(125)](/filings/0001628280-24-047148.md) | [529 d](/filings/0001507605-26-000007.md) | [(533)](/filings/0001507605-26-000016.md) | [808](/filings/0001507605-26-000022.md) | [123](/filings/0001507605-25-000028.md) | [(1,709) d](/filings/0001507605-26-000007.md) | [(1,262)](/filings/0001507605-26-000016.md) | [(611)](/filings/0001507605-26-000022.md) |
| Diluted EPS | $ per share | [(0.34)](/filings/0001628280-24-047148.md) | not reported | [1.26](/filings/0001507605-25-000009.md) | [(0.72)](/filings/0001507605-25-000018.md) | [(0.42)](/filings/0001507605-25-000028.md) | not reported | [(1.55)](/filings/0001507605-26-000016.md) | [1.84](/filings/0001507605-26-000022.md) | [0.27](/filings/0001507605-25-000028.md) | not reported | [(3.31)](/filings/0001507605-26-000016.md) | [(1.60)](/filings/0001507605-26-000022.md) |
| Basic EPS | $ per share | [0.00](/filings/0001628280-24-047148.md) | not reported | [1.30](/filings/0001507605-25-000009.md) | [(0.72)](/filings/0001507605-25-000018.md) | [(0.42)](/filings/0001507605-25-000028.md) | not reported | [(1.55)](/filings/0001507605-26-000016.md) | [2.29](/filings/0001507605-26-000022.md) | [0.33](/filings/0001507605-25-000028.md) | not reported | [(3.31)](/filings/0001507605-26-000016.md) | [(1.60)](/filings/0001507605-26-000022.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [357](/filings/0001628280-24-047148.md) | [357](/filings/0001507605-26-000007.md) | [324](/filings/0001507605-25-000009.md) | [256](/filings/0001507605-25-000018.md) | [164](/filings/0001507605-25-000028.md) | [392](/filings/0001507605-26-000007.md) | [196](/filings/0001507605-26-000016.md) | [109](/filings/0001507605-26-000022.md) | [826](/filings/0001507605-25-000028.md) | [547](/filings/0001507605-26-000022.md) | [514](/filings/0001507605-26-000016.md) | [421](/filings/0001507605-26-000022.md) |
| Current assets | $m | [433](/filings/0001493152-23-039927.md) | [1,030](/filings/0001507605-25-000003.md) | [1,641](/filings/0001628280-24-022243.md) | [372](/filings/0001628280-24-034196.md) | [239](/filings/0001628280-24-047148.md) | [470](/filings/0001507605-26-000007.md) | [292](/filings/0001507605-25-000009.md) | [236](/filings/0001507605-25-000018.md) | [962](/filings/0001507605-25-000028.md) | [664](/filings/0001507605-26-000022.md) | [611](/filings/0001507605-26-000016.md) | [527](/filings/0001507605-26-000022.md) |
| Total assets | $m | [1,384](/filings/0001493152-23-039927.md) | [1,991](/filings/0001507605-25-000003.md) | [2,957](/filings/0001628280-24-022243.md) | [3,117](/filings/0001628280-24-034196.md) | [3,580](/filings/0001628280-24-047148.md) | [6,801](/filings/0001507605-26-000007.md) | [6,444](/filings/0001507605-25-000009.md) | [7,721](/filings/0001507605-25-000018.md) | [9,153](/filings/0001507605-25-000028.md) | [7,287](/filings/0001507605-26-000022.md) | [4,949](/filings/0001507605-26-000016.md) | [4,349](/filings/0001507605-26-000022.md) |
| Current liabilities | $m | [38.2](/filings/0001493152-23-039927.md) | [33.8](/filings/0001507605-25-000003.md) | [71.1](/filings/0001628280-24-022243.md) | [99.2](/filings/0001628280-24-034196.md) | [59.8](/filings/0001628280-24-047148.md) | [95.2](/filings/0001507605-26-000007.md) | [368](/filings/0001507605-25-000009.md) | [441](/filings/0001507605-25-000018.md) | [459](/filings/0001507605-25-000028.md) | [522](/filings/0001507605-26-000022.md) | [331](/filings/0001507605-26-000016.md) | [592](/filings/0001507605-26-000022.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | not reported | [326](/filings/0001628280-24-025261.md) | not reported | not reported | [619](/filings/0001628280-24-047148.md) | [2,447](/filings/0001507605-26-000007.md) | [2,299](/filings/0001507605-25-000009.md) | [2,251](/filings/0001507605-25-000018.md) | [3,248](/filings/0001507605-25-000028.md) | [3,202](/filings/0001507605-26-000022.md) | [2,218](/filings/0001507605-26-000016.md) | [1,932](/filings/0001507605-26-000022.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001628280-24-025261.md) | not reported | not reported | not reported | [0.0](/filings/0001507605-26-000007.md) | not reported | not reported | not reported | [398](/filings/0001507605-26-000022.md) | [198](/filings/0001507605-26-000016.md) | [485](/filings/0001507605-26-000022.md) |
| Shareholders' equity | $m | [1,020](/filings/0001493152-23-039927.md) | [1,616](/filings/0001507605-25-000003.md) | [2,477](/filings/0001628280-24-022243.md) | [2,643](/filings/0001628280-24-034196.md) | [2,856](/filings/0001628280-24-047148.md) | [4,129](/filings/0001507605-26-000007.md) | [3,725](/filings/0001507605-25-000009.md) | [4,792](/filings/0001507605-25-000018.md) | [5,158](/filings/0001507605-25-000028.md) | [3,472](/filings/0001507605-26-000022.md) | [2,232](/filings/0001507605-26-000016.md) | [1,661](/filings/0001507605-26-000022.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(81.6) d](/filings/0001628280-24-047148.md) | [(91.2) d](/filings/0001507605-26-000007.md) | [(88.3)](/filings/0001507605-25-000009.md) | [(115) d](/filings/0001507605-25-000018.md) | [(160) d](/filings/0001507605-25-000028.md) | [(313) d](/filings/0001507605-26-000007.md) | [(215)](/filings/0001507605-26-000016.md) | [(163) d](/filings/0001507605-26-000022.md) | [(199) d](/filings/0001507605-25-000028.md) | [(225) d](/filings/0001507605-26-000007.md) | [(247)](/filings/0001507605-26-000016.md) | [(224) d](/filings/0001507605-26-000022.md) |
| Capital expenditure | $m | [2.5 d](/filings/0001628280-24-047148.md) | [1.8 d](/filings/0001507605-26-000007.md) | [9.1](/filings/0001507605-25-000009.md) | [17.2 d](/filings/0001507605-25-000018.md) | [38.0 d](/filings/0001507605-25-000028.md) | [187 d](/filings/0001507605-26-000007.md) | [38.9](/filings/0001507605-26-000016.md) | [119 d](/filings/0001507605-26-000022.md) | [84.8 d](/filings/0001507605-25-000028.md) | [164 d](/filings/0001507605-26-000007.md) | [79.5](/filings/0001507605-26-000016.md) | [14.8 d](/filings/0001507605-26-000022.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-047148.md) | [0.4 d](/filings/0001507605-26-000007.md) | [16.5](/filings/0001507605-25-000009.md) | [6.6 d](/filings/0001507605-25-000018.md) | [5.9 d](/filings/0001507605-25-000028.md) | [8.4 d](/filings/0001507605-26-000007.md) | [20.4](/filings/0001507605-26-000016.md) | [15.2 d](/filings/0001507605-26-000022.md) | [7.7 d](/filings/0001507605-25-000028.md) | [3.7 d](/filings/0001507605-26-000007.md) | [7.5](/filings/0001507605-26-000016.md) | [7.7 d](/filings/0001507605-26-000022.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [117](/filings/0001493152-23-039927.md) | [169](/filings/0001628280-24-025261.md) | [168](/filings/0001628280-24-034196.md) | [184](/filings/0001628280-24-047148.md) | [268](/filings/0001507605-25-000009.md) | [279](/filings/0001507605-25-000018.md) | [295](/filings/0001507605-25-000028.md) | [344](/filings/0001507605-26-000016.md) | [441](/filings/0001507605-26-000022.md) | [470](/filings/0001507605-25-000028.md) | [380](/filings/0001507605-26-000016.md) | [382](/filings/0001507605-26-000022.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 386,299,297 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001507605-26-000022.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.